{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T09:46:53Z","timestamp":1695635213974},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm Res"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf02280994","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T16:31:27Z","timestamp":1138206687000},"page":"293-298","source":"Crossref","is-referenced-by-count":4,"title":["The effects of mesoporphyrin on experimental arthritis in mice"],"prefix":"10.1007","volume":"45","author":[{"given":"H.","family":"Nagai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02280994_CR1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.154.3.688","volume":"154","author":"PH Wooley","year":"1981","unstructured":"Wooley PH, Luthra HS, David CS. Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates. J Exp Med 1981;154:688\u2013700.","journal-title":"J Exp Med"},{"key":"BF02280994_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI110495","volume":"69","author":"JM Stuart","year":"1982","unstructured":"Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 1982;69:673\u201383.","journal-title":"J Clin Invest"},{"key":"BF02280994_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.155.1.1","volume":"155","author":"JM Stuart","year":"1982","unstructured":"Stuart JM, Cremer MA, Kang AN, et al. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG antibodies can cause arthritis. J Exp Med 1982;155:1\u201316.","journal-title":"J Exp Med"},{"key":"BF02280994_CR4","first-page":"347","volume":"8","author":"P Niver","year":"1986","unstructured":"Niver P, Susan H, Orzechowski RF, et al. Humoral and cellular immunologic aspects of adjuvant and collagen arthritis in rats. J Immunopharmacol 1986;8:347\u201370.","journal-title":"J Immunopharmacol"},{"key":"BF02280994_CR5","first-page":"295","volume":"23","author":"WJ Mccune","year":"1980","unstructured":"Mccune WJ, Trenthmam DE, David JR. Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. Arthr Rheum 1980;23:295\u2013306.","journal-title":"Arthr Rheum"},{"key":"BF02280994_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0008-8749(81)90015-0","volume":"63","author":"RA Dynesiums-trentham","year":"1981","unstructured":"Dynesiums-trentham RA, Rowland D, Trentham DE, et al. Rat leukocyte inhibitory factor. Similarities to human LIF and generation by cells from rats with collagen-induced arthritis. Cell Immunol 1981;63:362\u201373.","journal-title":"Cell Immunol"},{"key":"BF02280994_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-3083.1985.tb01884.x","volume":"22","author":"R Holmdahl","year":"1985","unstructured":"Holmdahl R, Klareskog L, Wigzell H, et al. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II specific T-cell lines and clones. Scand J Immunol 1985;22:295\u2013306.","journal-title":"Scand J Immunol"},{"key":"BF02280994_CR8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI109136","volume":"62","author":"DE Trentham","year":"1978","unstructured":"Trentham DE, Dynesius RA, David JR. Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Exp Invest 1978;62:359\u2013366.","journal-title":"J Clin Exp Invest"},{"key":"BF02280994_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0008-8749(92)90294-Y","volume":"142","author":"K Kakimoto","year":"1992","unstructured":"Kakimoto K, Nakamura T, Onoue K, et al. The effect of antiddhesion molecule antibody on the development of collagen-induced arthritis. Cell Immunol 1992;142:326\u201337.","journal-title":"Cell Immunol"},{"key":"BF02280994_CR10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0192-0561(93)90017-S","volume":"15","author":"Y Takeoka","year":"1993","unstructured":"Takeoka Y, Naiki M, Suehiro S, et al. 2-Buten-4-Olide (2-B4O) inhibits type II collagen-induced arthritis in Lewis rats. Int J Immunopharmac 1993;15:803\u201310.","journal-title":"Int J Immunopharmac"},{"key":"BF02280994_CR11","first-page":"64","volume":"44","author":"H Fuchigami","year":"1994","unstructured":"Fuchigami, H, Nishimura T, Kimura K, et al. Effect of actarit on type II collagen-induced arthritis in mice. Arzneim Forsch Drug Res 1994;44:64\u20138.","journal-title":"Arzneim Forsch Drug Res"},{"key":"BF02280994_CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1073\/pnas.92.2.517","volume":"92","author":"RJ Griffiths","year":"1995","unstructured":"Griffiths RJ, Pettipher ER, Showell HJ, et al. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl Acad Sci USA 1995;92:517\u201321.","journal-title":"Proc. Natl Acad Sci USA"},{"key":"BF02280994_CR13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(87)91158-5","volume":"II","author":"C Herzog","year":"1987","unstructured":"Herzog C, Walker C, M\u00fcller W, et al. Monoclonal anti-CD4 in arthritis. Lancet 1987;II:1461\u20132.","journal-title":"Lancet"},{"key":"BF02280994_CR14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0896-8411(89)80002-2","volume":"2","author":"C Herzog","year":"1989","unstructured":"Herzog C, Walker C, Pichler WJ, et al. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and criculating T cells. J Autoiummunol 1989;2:627\u201342.","journal-title":"J Autoiummunol"},{"key":"BF02280994_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0896-8411(91)90181-B","volume":"4","author":"D Goldberg","year":"1991","unstructured":"Goldberg D, Morel P, Bach J, et al. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmunol 1991;4:617\u201330.","journal-title":"J Autoimmunol"},{"key":"BF02280994_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780340202","volume":"34","author":"G Horneff","year":"1991","unstructured":"Horneff G, Burmester GR, Kalden JR, et al. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthr Rheum 1991;34:129\u201340.","journal-title":"Arthr Rheum"},{"key":"BF02280994_CR17","first-page":"325","volume":"18","author":"D Wendling","year":"1991","unstructured":"Wendling D, Wijdenes J, Morel-Fourrier, et al. Therapeutic use of minoclonal anti CD4 antibody in rheumatoid arthritis. J Rheumatol 1991;18:325\u20137.","journal-title":"J Rheumatol"},{"key":"BF02280994_CR18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/art.1780340504","volume":"34","author":"C Reiter","year":"1991","unstructured":"Reiter C, Kakavand B, Kr\u00fcger K, et al. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthr Rheum 1991;34:525\u201336.","journal-title":"Arthr Rheum"},{"key":"BF02280994_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/rheumatology\/30.6.459","volume":"30","author":"BW Kirkham","year":"1001","unstructured":"Kirkham BW, Pitzalis C, Panayi GS, et al. Monoclonal antibody treatment in rheumatoid arthritis. The clinical and immunological effects of a CD7 monoclonal antibody. Br J Rheumatol 1001;30:459\u201363.","journal-title":"Br J Rheumatol"},{"key":"BF02280994_CR20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-3083.1992.tb03102.x","volume":"36","author":"EHS Choy","year":"1992","unstructured":"Choy EHS, Chikanza IC, Panati GS, et al. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Scand J Immunol 1992;36:291\u20138.","journal-title":"Scand J Immunol"},{"key":"BF02280994_CR21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/art.1780361008","volume":"36","author":"PA Lubbe","year":"1993","unstructured":"Lubbe PA, Reiter C, Riethmuller G, et al. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthr Rheum 1993;36:1375\u20139.","journal-title":"Arthr Rheum"},{"key":"BF02280994_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/art.1780300102","volume":"30","author":"ME Weinblatt","year":"1987","unstructured":"Weinblatt ME, Coblyn JS, Austen KF, et al. Cyclosporin A treatment of refractory rheumatoid arthritis. Arthr Rheum 1987;30:11\u20137.","journal-title":"Arthr Rheum"},{"key":"BF02280994_CR23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7326\/0003-4819-109-11-863","volume":"109","author":"DE Yocum","year":"1988","unstructured":"Yocum DE, Klippel JH, Dougherty S, et al. Cyclosporin A in severe, treatment-refractory rheumatoid arthritis: a randomizied study. Ann Intern Med 1988;109:863\u20139.","journal-title":"Ann Intern Med"},{"key":"BF02280994_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-291X(91)90522-9","volume":"174","author":"H Stepien","year":"1991","unstructured":"Stepien H, Kunert-Radek J, Pawlikowski M, et al. Inhibitory effect of porphyrins on the proliferation of mouse spleen lymphocytes in vitro. Biochem Biophys Res Commun 1991;174:313\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02280994_CR25","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.4049\/jimmunol.144.11.4327","volume":"144","author":"A Yen","year":"1990","unstructured":"Yen A, Gigli I, Barret KE. Dual effects of protoporphyrin and long wave ultraviolet light on histamine release from rat peritoneal and cutaneous mast cells. J Immunol 1990;144:4327\u201332.","journal-title":"J Immunol"},{"key":"BF02280994_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1751-1097.1991.tb08476.x","volume":"55","author":"MA Musser","year":"1991","unstructured":"Musser MA, Fiel RJ. Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol 1991;55:119\u201323.","journal-title":"Photochem Photobiol"},{"key":"BF02280994_CR27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1254\/jjp.33.819","volume":"33","author":"H Nagai","year":"1983","unstructured":"Nagai H, Nishiyori T, Daikoku M, et al. Immunopharmacological studies of sodium copper chlorphyllin. Jpn J Pharmacol 1983;33:819\u201328.","journal-title":"Jpn J Pharmacol"},{"key":"BF02280994_CR28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02028120","volume":"37","author":"H Nagai","year":"1992","unstructured":"Nagai H, Kitagaki K, Kuwabara K, et al. Anti-inflammatory properties of zinc protoporphyrin disodium. Agents Actions 1992;37:273\u201383.","journal-title":"Agents Actions"},{"key":"BF02280994_CR29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/283666a0","volume":"283","author":"JS Courtenay","year":"1980","unstructured":"Courtenay JS, Pullman MJ, Mosdale B, et al. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666\u20138.","journal-title":"Nature"},{"key":"BF02280994_CR30","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.130.6.2689","volume":"130","author":"DE Trentham","year":"1983","unstructured":"Trentham DE, Dynesius-trentham RA. Attenuation of an adjuvant arthritis by type II collagen. J. Immunol 1983;130:2689\u201392.","journal-title":"J. Immunol"},{"key":"BF02280994_CR31","doi-asserted-by":"crossref","first-page":"PL233","DOI":"10.1016\/0024-3205(94)00543-5","volume":"55","author":"H Nagai","year":"1994","unstructured":"Nagai H, Takaoka Y, Mori H, et al. The model of arthritis induced by superantigen. Life Science 1994;55:PL233\u201357.","journal-title":"Life Science"},{"key":"BF02280994_CR32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1084\/jem.139.3.528","volume":"139","author":"PH Lagrange","year":"1974","unstructured":"Lagrange PH, Mackaness GB, Miller TE. Influence of dose and route of antigen injection on the immunological of T cells. J Exp Med 1974;139:528\u201342.","journal-title":"J Exp Med"},{"key":"BF02280994_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.1993.tb03360.x","volume":"91","author":"ED Silverman","year":"1993","unstructured":"Silverman ED, Isacovics B, Laxer RM, et al. Synovial fluid cells in juvenile arthritis. Evidence of selective T cell migration to inflamed tissue. Clin Exp Immunol 1993;91:90\u20135.","journal-title":"Clin Exp Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02280994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02280994\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02280994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T08:59:46Z","timestamp":1683363586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02280994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF02280994"],"URL":"https:\/\/doi.org\/10.1007\/bf02280994","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}